vTv Therapeutics (VTVT) Proxy filing summary

Executive summary

• Adjourned annual meeting rescheduled for June 26, 2026, to allow review of a new executive compensation proposal.

• Stockholders will vote on director elections, auditor ratification, and an advisory say-on-pay proposal.

• Revised proxy materials and voting instructions provided, with extended deadlines for voting.

Voting matters and shareholder proposals

• Proposal 1: Elect seven director nominees to serve until the next annual meeting.

• Proposal 2: Ratify Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.

• Proposal 3: Advisory vote to approve named executive officer compensation, added via supplement.

• Board recommends voting “FOR” all three proposals.

• Voting can be done online, by phone, by mail, or virtually at the meeting.

Board of directors and corporate governance

• Seven director nominees listed: Srinivas Akkaraju, Raymond Cheong, Fahed Al Marzooqi, Richard S. Nelson, Anne M. Phillips, Paul Sekhri, Daniel K. Spiegelman.

• Directors to serve until the next annual meeting or until successors are elected and qualified.